HMGCR and cancer: On a different front, exposure to the anti-cancer cardiotoxic drug doxorubicin downregulated the HMG-CoA reductase in cancer cells, as previously reported for B[a]P [18], with the consequent reduction of cholesterol and lipid rafts [157].